Cargando…

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

BACKGROUND: In a previous randomised controlled phase 2 trial, intravenous infusion of salbutamol for up to 7 days in patients with acute respiratory distress syndrome (ARDS) reduced extravascular lung water and plateau airway pressure. We assessed the effects of this intervention on mortality in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Fang Gao, Perkins, Gavin D, Gates, Simon, Young, Duncan, McAuley, Daniel F, Tunnicliffe, William, Khan, Zahid, Lamb, Sarah E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lancet Publishing Group 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266479/ https://www.ncbi.nlm.nih.gov/pubmed/22166903 http://dx.doi.org/10.1016/S0140-6736(11)61623-1

Ejemplares similares

Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome
por: Perkins, Gavin D, et al.
Publicado: (2011)

The Beta Agonist Lung Injury TrIal (BALTI) - prevention trial protocol
por: Perkins, Gavin D, et al.
Publicado: (2011)

Bench-to-bedside review: β(2)-Agonists and the acute respiratory distress syndrome
por: Perkins, Gavin D, et al.
Publicado: (2004)

Tracing the Genetic Legacy of the Tibetan Empire in the Balti
por: Yang, Xing-Yan, et al.
Publicado: (2020)

Ethnobotany of the Balti community, Tormik valley, Karakorum range, Baltistan, Pakistan
por: Abbas, Zaheer, et al.
Publicado: (2016)

Clinically relevant concentrations of beta agonists may stimulate alveolar fluid clearance in acute respiratory distress syndrome
por: Perkins, G, et al.
Publicado: (2004)

Acute respiratory distress syndrome
por: Sweeney, Rob Mac, et al.
Publicado: (2016)

Acute Respiratory Distress Syndrome
por: Adams, Claire E., et al.
Publicado: (2022)

Effect of prone position on pulmonary vascular permeability in acute respiratory distress syndrome
por: McAuley, D, et al.
Publicado: (2001)

Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome
por: Toner, Philip, et al.
Publicado: (2015)

Guidelines on the management of acute respiratory distress syndrome
por: Griffiths, Mark J D, et al.
Publicado: (2019)

Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome
por: Nathani, Nazim, et al.
Publicado: (2008)

Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial
por: Gorman, Ellen, et al.
Publicado: (2020)

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial
por: Gorman, Ellen, et al.
Publicado: (2022)

Comparative Assessment of Medicinal Plant Utilization among Balti and Shina Communities in the Periphery of Deosai National Park, Pakistan
por: Abbas, Zaheer, et al.
Publicado: (2021)

Non-invasive respiratory support strategies in COVID-19
por: Gorman, Ellen, et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome Subphenotypes beyond the Syndrome: A Step toward Treatable Traits?
por: Reddy, Kiran, et al.
Publicado: (2021)

Individual patient data analysis of tidal volumes used in three large randomized control trials involving patients with acute respiratory distress syndrome
por: Poole, J., et al.
Publicado: (2017)

Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial
por: Lall, Ranjit, et al.
Publicado: (2021)

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial
por: Gorman, Ellen, et al.
Publicado: (2021)

COVID-19–related Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Corticosteroids: Time for More Precision?
por: Reddy, Kiran, et al.
Publicado: (2021)

Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials
por: Sinha, Pratik, et al.
Publicado: (2021)

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial
por: Agus, A., et al.
Publicado: (2017)

Effects of intravenous sivelestat sodium on prevention of acute respiratory distress syndrome in patients with sepsis: study protocol for a double-blind multicentre randomised controlled trial
por: Ma, Shaolei, et al.
Publicado: (2023)

Issues in the design and conduct of a multicentre trial in UK ambulance services
por: Gates, Simon, et al.
Publicado: (2013)

Beta 2 antagonism in acute respiratory failure
por: Sweeney, Rob Mac, et al.
Publicado: (2010)

The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial
por: McKelvey, Michael C., et al.
Publicado: (2023)

Investigating causal mechanisms in randomised controlled trials
por: Lee, Hopin, et al.
Publicado: (2019)

Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies
por: Verghis, Rejina Mariam, et al.
Publicado: (2023)

biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis (ADAPT-Sepsis): A protocol for a multicentre randomised controlled trial
por: Dark, Paul, et al.
Publicado: (2023)

Reply to Zhang and Hei: Mesenchymal Stem Cell–derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation–supported Acute Respiratory Distress Syndrome?
por: Millar, Jonathan E., et al.
Publicado: (2020)

Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review
por: Fitzgerald, Marianne, et al.
Publicado: (2014)

Prevention of post-operative complications by using a HMG-CoA reductase inhibitor in patients undergoing one-lung ventilation for non-cardiac surgery: study protocol for a randomised controlled trial
por: Shyamsundar, Murali, et al.
Publicado: (2018)

Accuracy of LightCycler® SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol
por: Dark, Paul, et al.
Publicado: (2012)

The Impact of Aging in Acute Respiratory Distress Syndrome: A Clinical and Mechanistic Overview
por: Brown, Ryan, et al.
Publicado: (2020)

Automation of oxygen titration in patients with acute respiratory distress at the emergency department. A multicentric international randomised controlled study
por: L'Her, E, et al.
Publicado: (2015)

0995. Aspirin reduces neutrophilic pulmonary inflammation in a human model of acute respiratory distress syndrome induced by inhaled lipopolysaccharide
por: Hamid, U Imran, et al.
Publicado: (2014)

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
por: Dixon, Barry, et al.
Publicado: (2021)

Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study
por: Perkins, Gavin D, et al.
Publicado: (2003)

Type XVIII collagen degradation products in acute lung injury
por: Perkins, Gavin D, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ebj11vdrio010nfnefco7jd28i